Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial
Robert S. Wallis, Sibuse Ginindza, Trevor Beattie, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 8, pp. 897-908
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Host-directed immunotherapy of viral and bacterial infections: past, present and future
Robert S. Wallis, Anne O’Garra, Alan Sher, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 121-133
Open Access | Times Cited: 157
Antibiotics in the clinical pipeline as of December 2022
Mark S. Butler, Ian R. Henderson, Robert J. Capon, et al.
The Journal of Antibiotics (2023) Vol. 76, Iss. 8, pp. 431-473
Open Access | Times Cited: 139
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
Giovanni Battista Migliori, Florian M. Marx, Nicolino Ambrosino, et al.
The International Journal of Tuberculosis and Lung Disease (2021) Vol. 25, Iss. 10, pp. 797-813
Open Access | Times Cited: 120
New developments in tuberculosis diagnosis and treatment
Cara M. Gill, Lorraine Dolan, Laura M. Piggott, et al.
Breathe (2022) Vol. 18, Iss. 1, pp. 210149-210149
Open Access | Times Cited: 112
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people
Olena Ivanova, Verena Hoffmann, Christoph Lange, et al.
European Respiratory Review (2023) Vol. 32, Iss. 168, pp. 220221-220221
Open Access | Times Cited: 48
A Review of Antibacterial Candidates with New Modes of Action
Mark S. Butler, Waldemar Vollmer, Emily C. A. Goodall, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 10, pp. 3440-3474
Open Access | Times Cited: 19
Inducible antibacterial responses in macrophages
Matthew J. Sweet, Divya Ramnath, Amit Singhal, et al.
Nature reviews. Immunology (2024) Vol. 25, Iss. 2, pp. 92-107
Closed Access | Times Cited: 17
Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection
Annuurun Nisa, Franciele Kipper, Dipak Panigrahy, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 5, pp. C1444-C1474
Open Access | Times Cited: 55
Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
Andrey D. Bondarev, Misty M. Attwood, Jörgen Jönsson, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
mTOR-regulated mitochondrial metabolism limits mycobacterium-induced cytotoxicity
Antonio J. Pagán, Lauren J. Lee, Joy Edwards-Hicks, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3720-3738.e13
Open Access | Times Cited: 42
Recent advances in the treatment of tuberculosis
Ilaria Motta, Martin J. Boeree, Dumitru Chesov, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 9, pp. 1107-1114
Open Access | Times Cited: 34
Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
Khushbu Sharma, Faraz Ahmed, Tarina Sharma, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17362-17380
Open Access | Times Cited: 28
Natural products in anti-tuberculosis host-directed therapy
Xuejiao Huang, Douglas B. Lowrie, Xiao‐Yong Fan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116087-116087
Open Access | Times Cited: 15
Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of Mycobacterium tuberculosis to Bedaquiline, Delamanid, and Pretomanid
Anjali Negi, Summaya Perveen, Ria Gupta, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2264-2286
Closed Access | Times Cited: 12
Drug Repurposing Against Antibiotic Resistant Bacterial Pathogens
Manya Aggarwal, Anushree Patra, Ishita Awasthi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116833-116833
Closed Access | Times Cited: 9
Host-directed therapy for tuberculosis
Na Tian, Hongqian Chu, Qi Li, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Auranofin: Past to Present, and repurposing
Masamichi Yamashita
International Immunopharmacology (2021) Vol. 101, pp. 108272-108272
Open Access | Times Cited: 53
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
Andrew R. DiNardo, Tanmay Gandhi, Jan Heyckendorf, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 3, pp. 2102263-2102263
Open Access | Times Cited: 33
Transcriptomics for child and adolescent tuberculosis*
Myrsini Kaforou, Claire Broderick, Ortensia Vito, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 97-122
Open Access | Times Cited: 29
Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus
Li Zhao, Ke Fan, Xue‐Zhi Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis
Robert S. Wallis, Issa Sabi, Julieth Lalashowi, et al.
NEJM Evidence (2024) Vol. 3, Iss. 9
Closed Access | Times Cited: 7
TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis –induced immune tolerance
Abhimanyu Abhimanyu, Santiago Carrero Longlax, Tomoki Nishiguchi, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 7
Immunopathology in human tuberculosis
Thomas J. Scriba, Mahlatse Maseeme, Carly Young, et al.
Science Immunology (2024) Vol. 9, Iss. 102
Closed Access | Times Cited: 6
T-Cell Exhaustion in Mycobacterium tuberculosis and Nontuberculous Mycobacteria Infection: Pathophysiology and Therapeutic Perspectives
Andrea Lombardi, Simone Villa, Valeria Castelli, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2460-2460
Open Access | Times Cited: 35
Drug-resistant tuberculosis: advances in diagnosis and management
Gunar Günther, Nunurai Ruswa, Peter M. Keller
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 3, pp. 211-217
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top